Jill E. Sackman, PhD is a senior consultant at Numerof & Associates, Inc.
Biopharma companies should not overlook India's growing market.
The biopharmaceutical industry contemplates product innovation within the changing landscape of healthcare.
The pharmaceutical industry grows despite conflict in the Middle East.
The bio-pharmaceutical business outlook in South Korea remains positive
A unique demographic and payer mix make ASEAN an increasingly attractive region.
Eastern Europe is moving towards a goal of harmonized regulations.
An introduction to a new series on manufacturing within global markets.
The industry must be prepared for the impact of the sweeping changes expected from the new legislation.